Sage Rhino Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
1,178
+39
+3% +$7.17K 0.04% 320
2026
Q1
$215K Sell
1,139
-149
-12% -$31.4K 0.04% 278
2025
Q4
$256K Buy
1,288
+6
+0.5% +$1.21K 0.05% 223
2025
Q3
$260K Sell
1,282
-32
-2% -$5.68K 0.05% 212
2025
Q2
$231K Sell
1,314
-213
-14% -$32.1K 0.05% 219
2025
Q1
$205K Sell
1,527
-113
-7% -$14.9K 0.05% 235
2024
Q4
$207K Sell
1,640
-65
-4% -$9.66K 0.05% 239
2024
Q3
$283K Sell
1,705
-6
-0.4% -$907 0.06% 186
2024
Q2
$228K Buy
+1,711
New +$206K 0.05% 200

Other funds holding THC

Sage Rhino Capital's THC Position: Q2 2026 in Review

Sage Rhino Capital increased its Tenet Healthcare (THC) stake by 3.4% in Q2 2026, buying an estimated $7.17K and bringing the position to 1,178 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #320.

Sage Rhino Capital first reported a position in THC in Q2 2024 and has held it in 9 quarters since. The position peaked at $283K in Q3 2024. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Sage Rhino Capital held 1,178 shares of Tenet Healthcare worth $220K as of Q2 2026.
  • Sage Rhino Capital bought 39 Tenet Healthcare shares in Q2 2026, an estimated $7.17K.
  • Tenet Healthcare made up 0.04% of Sage Rhino Capital's portfolio in Q2 2026, its #320 holding.
  • Sage Rhino Capital first reported a position in Tenet Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Sage Rhino Capital's Tenet Healthcare position peaked at $283K in Q3 2024.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.